Dr. Minnie Abromowitch MD
Hematologist (Pediatric) | Pediatric Hematology-Oncology
988095 Nebraska Medical Ctr Omaha NE, 68198About
Dr. Minnie Abromowitch is a pediatric hematologist practicing in Omaha, NE. Dr. Abromowitch specializes in treating children that have a blood disease or cancer. Such blood diseases include disorders of red blood cells, white blood cells and/or platelets. The types of cancers that Dr. Abromowitch treats include leukemias, lymphomas and certain tumors. Dr. Abromowitch can also treat bleeding disorders in children. Pediatric hematologists can be found in childrens hospitals, community hospitals, university medical centers and more.
Education and Training
Univ Of Manitoba- Fac Of Med- Winnipeg- Man- Canada 1973
Board Certification
PediatricsAmerican Board of PediatricsABP- Pediatric Hematology-Oncology
Provider Details
Clinical Trials
- Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
- Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
- Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
- Study of Kidney Tumors in Younger Patients
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
- Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
- Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
- Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
- Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
- Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
- Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
- Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
- Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
- Selumetinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
- Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
- Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
- Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB or Stage IIIB-IVB Hodgkin Lymphoma
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
- Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Dr. Minnie Abromowitch MD's Practice location
Practice At 988095 Nebraska Medical Ctr
988095 Nebraska Medical Ctr -Omaha, NE 68198Get Direction
Dr. Minnie Abromowitch MD's reviews
Write ReviewRecommended Articles
- Why Is the Cause of Multiple Sclerosis Unknown?
It is a challenging experience for a doctor to break the news of the disease to a patient suffering from multiple sclerosis (MS) as the cause of the disease is unknown.Multiple sclerosis is an autoimmune disease where the immune system attacks its tissues. It is a progressive neurological disorder....
![]()
What Is Pneumocystis Carinii Pneumonia?Pneumocystis carinii pneumonia (PCP) is a very serious disease, which is characterized by a fluid buildup and inflammation in the lungs. This lung infection is caused by the fungus Pneumocystis jiroveci. It is an opportunistic disease that usually infects immunosuppressed individuals, especially...
![]()
PurpuraPurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...
![]()
Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant RecipientsLymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
![]()
How Is Leukemia Diagnosed?Leukemia in its early stages may present no signs or symptoms, as these only appear when the leukemia cells have taken over a large number of normal blood cells. A person with leukemia is very lucky indeed if early-stage detection occurs incidentally, through a routine blood test or one done for...
![]()
Potential Causes of LeukopeniaIntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
Nearby Providers
![]()
Dr. Harold M Maurer MD988095 Nebraska Medical Ctr Omaha NE 68198![]()
Dr. Bruce G Gordon MD988095 Nebraska Medical Ctr Omaha NE 68198![]()
Dr. Don W. Coulter MD982168 Nebraska Medical Center Omaha NE 68198![]()
Dr. Melissa Acquazzino M.D.EMILE 42ND ST OMAHA NE 68198![]()
Dr. Phylis I Warkentin MD988095 Nebraska Medical Ctr Omaha NE 68198![]()
Taylor Elise Losole M.D.982185 NEBRASKA MEDICAL CTR OMAHA NE 68198
Nearest Hospitals
BOYS TOWN NATIONAL RESEARCH HOSPITALl
555 NORTH 30TH ST OMAHA NE 68131CHI HLTH CREIGHTON UNIVERSITY MED CTR-BERGAN MERCYl
601 NORTH 30TH ST OMAHA NE 68131